If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 118.00
Bid: 118.00
Ask: 119.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.847%)
Open: 118.00
High: 119.00
Low: 118.00
Prev. Close: 118.00
RECI Live PriceLast checked at -
Real Estate Credit Investments is an Investment Trust

To provide attractive and stable returns, primarily through quarterly dividends, by exposure to a diversified portfolio of real estate credit investments, predominantly comprising real estate loans and bonds, focusing in UK and Western Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buyback Programme

31 Aug 2023 07:00

RNS Number : 8247K
Real Estate Credit Investments Ltd
31 August 2023
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO ANY US PERSONS OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSON, WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

This announcement contains inside information as defined under the Market Abuse Regulation. (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. This announcement has been prepared by, and is the sole responsibility of, Real Estate Credit Investments Limited. This announcement has been released by Lucy McDowall of Aztec Financial Services (Guernsey) Limited, Secretary of the Company.

31 August 2023

Real Estate Credit Investments Limited

Share Buyback Programme

The Board of Directors of Real Estate Credit Investments Limited ("RECI" or the "Company") announces that it intends to commence a share buyback programme (the "Programme").

The Board consistently maintains its practice of considering all options when assessing the levels of cash to be retained or deployed by the Company from time to time and how any such cash available for deployment should be allocated. Excess cash is regarded as the cash available following recognition of the obligation to ensure sufficient cash resources to pay, inter alia, the Company's expenses, borrowings, dividends and fund its ongoing contractual loan commitments, from time to time ("Available Cash"). In the current circumstances, the Board has chosen to make an allocation of Available Cash available to finance the Programme alongside potential reinvestment into new enhanced return investment opportunities as and when appropriate.

The Programme will extend from today's date for the period up to the end of the Company's current financial year on 31 March 2024. The aggregate purchase price of all shares acquired under the Programme will be no greater than £5.0 million.

The Programme will occur within the limitations of RECI's existing general authority to purchase no more than 34,376,938 ordinary shares of no par value each ("Ordinary Shares") as granted by shareholders at the Company's annual general meeting held on 15 September 2022 (with such authority to be renewed at the forthcoming annual general meeting). The purpose of the Programme is to reduce the total issued share capital of the Company.

The Company has appointed Liberum Capital Limited ("Liberum") to make market purchases of Ordinary Shares in respect of the Programme. Liberum will purchase the Ordinary Shares as principal (and not as agent) and sell them on to the Company. The Company intends that any Ordinary Shares purchased by the Company will be held in treasury.

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Liberum's engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's 2022 annual general meeting with such authority to be renewed at the forthcoming annual general meeting; and the EU Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended); and Chapter 12 of the Financial Conduct Authority's Listing Rules.

The maximum price payable per share (exclusive of expenses) must not exceed the higher of: (i) 105% of the average middle market quotations for the five business days preceding the date of purchase; and (ii) the higher of the last independent trade and the highest current independent bid on the London Stock Exchange.

A buy-back of Ordinary Shares on any trading day may represent a significant proportion of the daily trading volume in the Shares on the Exchange (and could exceed the 25% limit of the average daily trading volume of the preceding 20 business days as referred to in the Commission Delegated Regulation (EU) No. 2016/1052 on buy-back programmes (as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018)).

Any purchase of Ordinary Shares by the Company will be notified through an RIS announcement by no later than 7.30 a.m. on the following business day. Shareholders should note that whether a buyback of Ordinary Shares is made is based on a number of factors and, accordingly, no expectation or reliance should be placed on Liberum exercising such discretion on any one or more occasions. There is no guarantee that the Programme will be implemented in full or that any Ordinary Shares will be repurchased by the Company. The Programme will not impact the Company's existing Ordinary Share dividend policy, which will continue unaffected through the regular awards of quarterly dividends.

 

Enquiries:

Cheyne Capital Management (UK) LLP

+44 (0) 20 7968 7328

Richard Lang

 

 

Liberum Capital Limited (Corporate Broker)

+44 (0) 20 3100 2222

Shane Le Prevost

Richard Crawley

Edward Mansfield

Miquela Bezuidenhoudt

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSDFFISEDSESA
Date   Source Headline
6th Jan 20177:00 amRNSFact Sheet Announcement
7th Dec 20167:00 amRNSFact Sheet Announcement
30th Nov 20167:00 amRNSDividend Declaration - Preference Dividend
30th Nov 20167:00 amRNSDividend Declaration - Ordinary Dividend
30th Nov 20167:00 amRNSCondensed Interim Financial Report
30th Nov 20167:00 amRNSHalf-year Report
3rd Nov 20167:00 amRNSFact Sheet Announcement
25th Oct 201611:30 amRNSChange of Name
5th Oct 20167:00 amRNSFact Sheet Announcement
16th Sep 20162:00 pmRNSResult of AGM
7th Sep 20167:00 amRNSFact Sheet Announcement
18th Aug 20167:00 amRNSNotice of AGM
10th Aug 20163:00 pmRNSDividend Declaration - Preference Dividend
10th Aug 20163:00 pmRNSDividend Declaration - Ordinary Dividend
9th Aug 20167:00 amRNSFact Sheet Announcement
22nd Jul 20165:00 pmRNSDirector Declaration
12th Jul 20162:00 pmRNSDirector/PDMR Shareholding
7th Jul 201612:00 pmRNSFact Sheet Announcement
4th Jul 20167:00 amRNSDirector Declaration - Additional Directorship
1st Jul 201612:07 pmRNSDirectorate Change
17th Jun 20167:00 amRNSDividend Declaration - Ordinary Dividend
17th Jun 20167:00 amRNSFinal Results
17th Jun 20167:00 amRNSAnnual Financial Report
9th Jun 20167:00 amRNSDividend Declaration - Preference Dividend
7th Jun 20167:00 amRNSFact Sheet Announcement
31st May 20167:00 amRNSNotice of Resuts
6th May 20167:00 amRNSFact Sheet Announcement
13th Apr 201610:00 amRNSDirector/PDMR Shareholding
8th Apr 201611:33 amRNSFact Sheet Announcement
21st Mar 20162:00 pmRNSAppointment of New Director
18th Mar 20167:00 amRNSReturn of Capital to Cell Shareholders
4th Mar 20167:00 amRNSFact Sheet Announcement
10th Feb 20167:00 amRNSDividend Declaration - Ordinary Dividend
10th Feb 20167:00 amRNSDividend Declaration - Preference Dividend
3rd Feb 20167:00 amRNSFact Sheet Announcement
13th Jan 20169:56 amRNSDirector/PDMR Shareholding
6th Jan 20167:00 amRNSFact Sheet Announcement
7th Dec 20157:00 amRNSFact Sheet Announcement
27th Nov 20157:00 amRNSPreference Dividend Declaration
27th Nov 20157:00 amRNSOrdinary Dividend Declaration
27th Nov 20157:00 amRNSCondensed Interim Financial Report
27th Nov 20157:00 amRNSHalf Year Results
12th Nov 20157:00 amRNSNotice of Results
4th Nov 20157:00 amRNSFact Sheet Announcement
20th Oct 20154:40 pmRNSNew directorship notification under Listing Rules
19th Oct 20157:00 amRNSCompany Update
13th Oct 201512:28 pmRNSDirector/PDMR Shareholding
5th Oct 201512:00 pmRNSFact Sheet Announcement
4th Sep 20157:00 amRNSFact Sheet Announcement
12th Aug 20153:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.